Octreotide Reduces the Reoccurrence of Ventricular Assist Device Related Gastrointestinal Bleeding
The Journal of Heart and Lung Transplantation(2017)
Abstract
Gastrointestinal bleeding (GIB) is a frequent complication after implantation of a left ventricular assist device (LVAD). In patients without an LVAD, octreotide is used to treat GIB as well as bleeding prophylaxis for vascular ectasias. We evaluated the efficacy of outpatient administration of octreotide to prevent reoccurrence of an LVAD related GIB.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined